Recent Comments

Comment RSS

Neuron News and Research RSS Feed - Neuron News and Research

Review of R&D and novel therapeutic challenges in neurological disorders

20. November 2009 04:39
Research and Markets (http://www.researchandmarkets.com/research/fae4d4/neurological_disea) has announced the addition of Decision Resources, Inc.'s new report "Neurological Disease: Early-Stage R&D and Dealmaking" to their offering. [More]

New mathematical model may hasten drug development for Parkinson's Disease

19. November 2009 01:52
Australian scientists have significantly advanced our understanding of dopamine release from nerve cells, findings that should speed the development of more effective drugs for treating Parkinson's Disease. [More]

Gene that tells embryonic stem cells when to stop producing neurons identified

18. November 2009 07:00
Researchers from North Carolina State University have identified a gene that tells embryonic stem cells in the brain when to stop producing nerve cells called neurons. The research is a significant advance in understanding the development of the nervous system, which is essential to addressing conditions such as Parkinson's disease, Alzheimer's disease and other neurological disorders. [More]

Brain size does not affect animal's capability for intelligent behavior, says new research

18. November 2009 00:25
Tiny insects could be as intelligent as much bigger animals, despite only having a brain the size of a pinhead, say scientists at Queen Mary, University of London. [More]

Posted in: Medical Science News

Tags: , ,

Mithridion reports progress with its potential oral small-molecule drugs for AD and schizophrenia

13. November 2009 01:22
Mithridion, Inc., a biopharmaceutical company focusing on developing drugs for serious Central Nervous System (CNS) disorders, announced today progress with its pipeline of potential oral small-molecule drugs for Alzheimer's disease (AD) and schizophrenia. [More]

Study: Mouse gene uncovers new strategy for treating Alzheimer's disease

12. November 2009 01:32
A new study reveals that a previously undiscovered mouse gene reduces the two major pathological perturbations commonly associated with Alzheimer's disease (AD). The research, published by Cell Press in the November 12 issue of the journal Neuron, finds that the novel gene interacts with a key cellular enzyme previously linked with AD pathology, thereby uncovering a new strategy for treating this devastating disorder. [More]

Researchers identify mouse gene that reduces the accumulation Alzheimer's plaques and tangles

12. November 2009 01:21
Investigators at Burnham Institute for Medical Research (Burnham) and colleagues have identified a novel mouse gene (Rps23r1) that reduces the accumulation of two toxic proteins that are major players in Alzheimer's disease: amyloid beta and tau. The amyloid and tau lowering functions of this gene were demonstrated in both human and mouse cells. [More]

Children with developmental dyslexia have difficulties separating relevant auditory information from irrelevant noise

12. November 2009 01:20
The vast majority of school-aged children can focus on the voice of a teacher amid the cacophony of the typical classroom thanks to a brain that automatically focuses on relevant, predictable and repeating auditory information, according to new research from Northwestern University. [More]

Posted in: Child Health News | Medical Condition News

Tags: , , , , ,

Avanir Pharmaceuticals unveils Star trial results for Zenvia in the treatment of PBA

11. November 2009 01:30
AVANIR Pharmaceuticals, Inc. today announced efficacy, safety and tolerability results from the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of patients with pseudobulbar affect (PBA). [More]

HFSP grant to develop molecular probes to study "cellular GPS" system

11. November 2009 00:47
An international group of researchers from Carnegie Mellon University, Goettingen Medical School in Germany and the University of Cambridge in the United Kingdom have received a Human Frontiers Science Program (HFSP) grant to develop molecular probes that will help researchers better understand the "cellular GPS" system that guides neurons to create a properly wired nervous system. [More]

Posted in: Medical Science News

Tags: , , , , , , ,

Second-quarter fiscal 2010 results announced by Repligen

5. November 2009 07:42
Repligen Corporation today reported results for the second quarter of fiscal year 2010, ended September 30, 2009. Total revenue for the quarter was $5,421,000 compared to total revenue of $5,090,000 for the second quarter of fiscal year 2009 ended September 30, 2008. [More]

Tetracycline-like compound raises hope for treatment of spinal muscular atrophy

5. November 2009 00:56
A chemical cousin of the common antibiotic tetracycline might be useful in treating spinal muscular atrophy (SMA), a currently incurable disease that is the leading genetic cause of death in infants. This is the finding of a research collaboration involving Adrian Krainer, Ph.D., of Cold Spring Harbor Laboratory (CSHL) and scientists from Paratek Pharmaceuticals and Rosalind Franklin University of Medicine and Science. [More]

Over 425 hospitals implement Capsule's medical device connectivity solution

4. November 2009 08:11
Capsule (www.capsuletech.com), the leading provider of medical device connectivity, today announced recent additions to its rapidly expanding list of hospitals that have implemented their solution. [More]

Posted in: Device / Technology News | Healthcare News

Tags: ,

Lipid may be vital to learning

31. October 2009 02:25
Saturated fats have a deservedly bad reputation, but Johns Hopkins scientists have discovered that a sticky lipid occurring naturally at high levels in the brain may help us memorize grandma's recipe for cinnamon buns, as well as recall how, decades ago, she served them up steaming from the oven. [More]

Posted in: Medical Science News

Tags: , , ,

Study: Gene therapy can reduce symptoms of Huntington's disease

31. October 2009 01:48
Researchers at the California Institute of Technology (Caltech) have shown that a highly specific intrabody (an antibody fragment that works against a target inside a cell) is capable of stalling the development of Huntington's disease in a variety of mouse models. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.